In this before-after multicenter study the authors tested the hypothesis that the prophylactic use of aprotinin compared to tranexamic acid could reduce the proportion of patients presenting severe perioperative bleeding.
Perioperative bleeding remains a real challenge for physicians managing cardiac surgical patients. In patients at high risk for excessive bleeding the prophylactic use of antifibrinolytics may be useful. This study propose to compare the efficacity and innocuity of aprotinin and tranexamic acid to reduce the proportion of patient presenting severe peri-operative bleeding according the Universal Definition of Perioperative Bleeding (UDPB) classification.
Study Type
OBSERVATIONAL
Enrollment
693
retrospective study: standard of care
Grenoble University Hospital
La Tronche, France
Lyon University Hospital
Lyon, France
Montpellier University Hospital
Montpellier, France
Nantes University Hospital
Nantes, France
Proportion of patients with severe peri-operative bleeding
Proportion of patients with severe peri-operative bleeding defined by an UDPB (the Universal Definition of Perioperative Bleeding ) classification of 3 and 4.
Time frame: day 30 after surgery
distribution of patients by UDPB classification category
proportion of patients with category 0 UDPB.
Time frame: day 30 after surgery
distribution of patients by UDPB classification category
proportion of patients with category 1 UDPB.
Time frame: day 30 after surgery
distribution of patients by UDPB classification category
proportion of patients with category 2 UDPB.
Time frame: day 30 after surgery
distribution of patients by UDPB classification category
proportion of patients with category 3 UDPB.
Time frame: day 30 after surgery
distribution of patients by UDPB classification category
proportion of patients with category 4 UDPB.
Time frame: day 30 after surgery
blood loss
post operative chest tube blood loss
Time frame: 24 hours after chest closure
rescue surgery for bleeding
proportion of rescue surgery for bleeding
Time frame: day 30 after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
North Val de Seine Paris University Hospital
Paris, France
Georges Pompidou European University Hospital
Paris, France
Bordeaux University Hospital
Pessac, France
length of stay
intensive care unit length of stay
Time frame: through intensive care unit discharge, an average of 30 days
length of stay
hospital length of stay
Time frame: through hospital discharge, an average of 30 days
KDIGO score greater than or equal to 2
acute kidney injury defined by KDIGO score greater than or equal to 2
Time frame: day 7 after surgery
mechanical ventilation time
duration of artificial ventilation (hours)
Time frame: through intensive care unit discharge, an average of 30 days
mechanical ventilation
need to use mechanical ventilation for more than 48 hours
Time frame: 48 hours after surgery
need for transfusion
need for labil blood products and medicinal products derived from blood
Time frame: up to 48 hours after surgery
need for transfusion
need for labil blood products and medicinal products derived from blood
Time frame: up to seven day after surgery
need for vasopressors/inotropes
need for use postoperative vasopressors/inotropes for more than 24 hours
Time frame: beyond 24 hours after surgery
vital status
mortality after surgery
Time frame: 30 days after surgery
new renal replacement therapy
need for renal replacement therapy
Time frame: up to day 30 after surgery
short term mechanical circulatory support
need for short term mechanical circulatory support (extra corporeal life support, Impella TM pump, intra aortic balloon pump)
Time frame: up to 30 day after surgery
myocardial infarction
occurrence of myocardial infarction
Time frame: up to 30 day after surgery
embolic or thrombotic event
occurrence of embolic or thrombotic event
Time frame: up to 30 day after surgery
stroke
occurrence of stroke
Time frame: up to 30 day after surgery